FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE G

MDR report key: 3936168 · Received July 15, 2014

Report

Report Number
2124215-2014-13792
Event Type
Injury
Date Received
July 15, 2014
Date of Event
June 23, 2014
Report Date
November 6, 2019
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Additional Manufacturer Narrative · 1

A PORTION OF THIS PRODUCT HAS BEEN RECEIVED FOR ANALYSIS. IF ANALYSIS IS COMPLETED ON THIS PRODUCT, THIS REPORT WILL BE UPDATED AT THAT TIME.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED LOSS OF CAPTURE (LOC) DURING ATRIAL FLUTTER ABLATION PROCEDURE. THIS LEAD WAS PROGRAMMED TO OFF-ELECTROCAUTERY MODE FOR VOO PACING. A BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) CONSULTANT DISCUSSED THAT WHEN THE DEVICE IS IN ELECTROCAUTERY MODE AND SEE AN EXTERNAL POWER SOURCE, THE DEVICE PACES AT SUB THRESHOLD LEVELS. THE PATIENT WAS PACEMAKER DEPENDENT. ADDITIONAL INFORMATION RECEIVED FROM THE FIELD REPRESENTATIVE INDICATED THAT LOC RESULTED IN GREATER THAN TWO SECONDS OF ASYSTOLE. THIS LEAD WAS RE-PROGRAMMED AND REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED THAT THIS LEAD WAS SURGICALLY ABANDONED DUE TO THE PREVIOUSLY REPORTED LOSS OF CAPTURE WITH ASYSTOLE. THIS LEAD WAS SEVERED AND A PORTION HAS BEEN RETURNED FOR ANALYSIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
412175 ENDOTAK RELIANCE G IMPLANTABLE LEAD NVY BOSTON SCIENTIFIC CORPORATION 0296 114738

Patients

Seq Age Sex Outcome Treatment
1 99 YR Hospitalization| R 1290| N160| 4087| 4554| 4088| 0296